摘要
背景:系统生物学和网络建模代表了当今开发基于预测和靶向治疗的精准医学的标志性方法。将健康和疾病作为人体系统的特性进行研究,可以通过定义分子相互作用和依赖性来理解基因型-表型关系。在这种情况下,代谢起着核心作用,因为它的相互作用得到了很好的表征,并且被认为是基因型-表型关联的重要指标。在代谢系统生物学中,基因组规模的代谢模型是整合多组学数据以及细胞、组织、条件特定信息的主要支架。对新陈代谢进行建模具有研究价值和预测价值。已经提出了几种方法来对系统进行建模,包括稳态或动力学方法,以及通过机器和深度学习来提取知识。 方法:本综述收集、分析和比较了用于探索代谢网络作为精准医学发展工具的合适数据和计算方法。为此,我们将其分为三个主要部分:“数据和数据库”、“方法和工具”以及“医学代谢网络”。在第一个中,我们收集了最常用的数据和相关数据库来构建和注释代谢模型。在第二部分中,我们报告了重建、模拟和解释代谢系统的最新方法和相关工具。最后,我们报告了最新的创新研究,这些研究利用代谢网络来研究几种病理状况,而不仅仅是与代谢直接相关的病理状况。 结论:我们认为这篇综述可以为不同学科的研究人员提供指导,从计算机科学到生物学和医学,探索新陈代谢作为所谓 P4 医学(预测性医学)的预测因子和目标的力量、挑战和未来前景。 、预防性、个性化和参与性)。
关键词: 代谢网络、生化数据库、精准医学、组学数据、数学建模、机器学习、深度学习。
Current Medicinal Chemistry
Title:Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Volume: 28 Issue: 32
关键词: 代谢网络、生化数据库、精准医学、组学数据、数学建模、机器学习、深度学习。
摘要:
Background: Systems biology and network modeling represent, nowadays, the hallmark approaches for the development of predictive and targeted-treatment based precision medicine. The study of health and disease as properties of the human body system allows the understanding of the genotype-phenotype relationship through the definition of molecular interactions and dependencies. In this scenario, metabolism plays a central role as its interactions are well characterized and it is considered an important indicator of the genotype- phenotype associations. In metabolic systems biology, the genome-scale metabolic models are the primary scaffolds to integrate multi-omics data as well as cell-, tissue-, condition- specific information. Modeling the metabolism has both investigative and predictive values. Several methods have been proposed to model systems, which involve steady-state or kinetic approaches, and to extract knowledge through machine and deep learning.
Methods: This review collects, analyzes, and compares the suitable data and computational approaches for the exploration of metabolic networks as tools for the development of precision medicine. To this extent, we organized it into three main sections: "Data and Databases", "Methods and Tools", and "Metabolic Networks for medicine". In the first one, we have collected the most used data and relative databases to build and annotate metabolic models. In the second section, we have reported the state-of-the-art methods and relative tools to reconstruct, simulate, and interpret metabolic systems. Finally, we have reported the most recent and innovative studies that exploited metabolic networks to study several pathological conditions, not only those directly related to metabolism.
Conclusion: We think that this review can be a guide to researchers of different disciplines, from computer science to biology and medicine, in exploring the power, challenges and future promises of the metabolism as predictor and target of the so-called P4 medicine (predictive, preventive, personalized and participatory).
Export Options
About this article
Cite this article as:
Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine, Current Medicinal Chemistry 2021; 28 (32) . https://dx.doi.org/10.2174/0929867328666201217103148
DOI https://dx.doi.org/10.2174/0929867328666201217103148 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Obesity-Driven Inflammation and Colorectal Cancer
Current Medicinal Chemistry Cytomegalovirus Infection in Pediatric Immunocompromised Hosts
Infectious Disorders - Drug Targets Neuropeptides as Therapeutic Targets in Anxiety Disorders
Current Pharmaceutical Design CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets “Self-Antigenic Universe” and Tuberculosis Vaccine Development
Current Pharmacogenomics and Personalized Medicine Monitoring and Surveillance of Obesity in the United States
Current Nutrition & Food Science A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Personalized Treatment of Obsessive-Compulsive Disorder: Radiology, EEG, Pharmacogenetics and Biochemistry
Current Pharmacogenomics and Personalized Medicine Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Materials Degradation in PVC Medical Devices, DEHP Leaching and Neonatal Outcomes
Current Medicinal Chemistry Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
Reviews on Recent Clinical Trials Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens
Recent Patents on Biotechnology Development of Mitotane Lipid Nanocarriers and Enantiomers: Two-in-One Solution to Efficiently Treat Adreno-Cortical Carcinoma
Current Medicinal Chemistry Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy
Clinical Cancer Drugs